A Phoenix man has admitted to participating in a scheme that brought unapproved performance-enhancing substances into the United States and sold them to consumers nationwide, according to federal authorities.
The U.S. Department of Justice announced that Jeffrey McIndoo and his company, JeffMac Investments LLC, operating as SARMS Pharm LLC, pleaded guilty to charges connected to the sale of selective androgen receptor modulators, or SARMs. The substances, often marketed for muscle growth and athletic performance, are not approved by the U.S. Food and Drug Administration.
Prosecutors said SARMS Pharm also admitted to conspiring to smuggle SARMs from China into the United States. Investigators found that the company generated approximately $3.5 million in sales from 2017 through 2022 by distributing the products.
As part of the plea agreement, the company will forfeit $1.8 million in proceeds and permanently shut down its operations. McIndoo, meanwhile, faces a potential prison sentence of up to one year.
Federal officials said the case underscores ongoing efforts to combat the illegal importation and distribution of unapproved substances. In a statement announcing the plea, Assistant Attorney General Brett A. Shumate said authorities remain focused on preventing smuggled SARMs from reaching consumers and entering the national marketplace.
The prosecution marks another step in the government’s broader crackdown on companies selling unapproved performance-enhancing products that bypass federal regulatory oversight.
